Lecturer, Medicine, Tufts Medical Center
Endocrinology
Dr. Andre T. Guay, MD
|
|
Give Review
Andre Guay practices Endocrinology. He attended Rutgers New Jersey Medical School. Rutgers New Jersey Medical School is ranked 76 in research and 0 in primary care medicine He has 1 awards "Fellow (FACE)". Doctor Andre T. Guay, MD is a published doctor. He published 87 publications, including: 'Asymptomatic ''big'' hyperprolactinemia in two men with pituitary adenomas.' He is registered with Medicare.
Publications
- Death by testosterone? We think not!
- Diagnosis and Treatment of Erectile Dysfunction for Reduction of Cardiovascular Risk.
- Dehydroepiandrosterone (DHEA)-A Precursor Steroid or an Active Hormone in Human Physiology (CME).
- Testosterone deficiency and risk factors in the metabolic Syndrome: implications for erectile dysfunction.
- Adverse Side Effects of 5α-Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients.
- Responses to the proposed DSM-V changes.
- Endocrine aspects of Male sexual dysfunctions.
- Absorption of testosterone gel 1% (Testim) from three different application sites.
- The emerging link between hypogonadism and metabolic Syndrome.
- Testosterone therapy in women with gynecological and sexual Disorders: a triumph of clinical endocrinology from 1938 to 2008.
- Testosterone therapy and breast cancer?
- ED2: erectile Dysfunction = endothelial Dysfunction.
- Testosterone and erectile physiology.
- Are androgens critical for penile erections in humans? Examining the clinical and preclinical evidence.
- Relation of endothelial cell function to erectile Dysfunction: implications for treatment.
- Incidence of metabolic syndrome and insulin resistance in a population With organic erectile dysfunction.
- Endocrine aspects of feMale sexual dysfunction.
- Improvement in erectile function in men With organic erectile dysfunction by correction of elevated cholesterol levels: a clinical observation.
- Endocrine aspects of sexual Dysfunction in men.
- Optimizing response to phosphodiesterase therapy: impact of risk-factor management.
- Prevalence of cardiovascular risk factors in erectile Dysfunction.
- Achieving treatment optimization With sildenafil citrate (Viagra) in patients With erectile dysfunction.
- Re: Long-term efficacy of sildenafil and tachyphylaxis effect.
- Screening for androgen Deficiency in women: methodological and interpretive issues.
- Are there variances of calculated free testosterone attributed to variations in albumin and sex hormone-binding globulin concentrations in men?
- Re: Skin necrosis caused by use of negative pressure device for erectile impotence.
- Re: Hyperprolactinemia and impotence: why, when and how to investigate.
- An adrenocorticotropic hormone-producing pheochromocytoma: diagnostic and immunohistochemical studies.
- Calcified pituitary tumor With hyperprolactinemia: selective removal by transsphenoidal adenectomy.
- Secretion of prolactin after acute and chronic stimulation of the breast: effect of timing during the menstrual cycle.
- Familial ciliary dyskinesis: a cause of infertility Without respiratory disease.
- Sertoli cell only Syndrome and normal gonadotropins.
- Normal penetration of hamster ova by human spermatozoa With dyskinetic motility.
- Male impotence.
- Asymptomatic ''big'' hyperprolactinemia in two men With pituitary adenomas.
- Myopathy of endogenous Cushing's Syndrome: a review of the clinical and electromyographic features in 8 patients.
- Susceptibility to subacute thyroiditis is genetically influenced: familial occurrence in identical twins.
- Germinal cell aplasia: response of luteinizing hormone (LH), follicle-stimulating hormone (FSH), and testosterone to LH/FSH-releasing hormone With histopathologic corr...
- Topical alprostadil (PGE1) for the treatment of feMale sexual arousal disorder: in-clinic evaluation of safety and efficacy.
- Does early morning versus late morning draw time influence apparent testosterone concentration in men aged > or =45 years? Data from the Hypogonadism In Males study.
- Re: Comparison of RigiScan and formal nocturnal penile tumescence testing in the evaluation of erectile rigidity.
- Decreased testosterone in regularly menstruating women With decreased libido: a clinical observation.
- Erectile Dysfunction. Are you prepared to discuss it?
- Sexual foreplay incontinence in men With erectile dysfunction after radical prostatectomy: a clinical observation.
- Non-insulin-dependent Diabetes mellitus and elevated serum ferritin level.
- Is the measurement of serum testosterone routinely indicated in men With erectile dysfunction?
- Hot flushes in men With pituitary adenoma.
- New perspectives in pheochromocytoma.
- Serum testosterone is associated With aggressive prostate cancer in older men: results from the Baltimore Longitudinal Study of Aging.
- Global experiences With vardenafil in men With erectile dysfunction and underlying conditions.
- Sexual Dysfunction in the diabetic patient.
- Assessment of the efficacy and safety of Viagra (sildenafil citrate) in men With erectile dysfunction during long-term treatment.
- Re: Classification of sexual Dysfunction for management of intracavernous medication-induced erections.
- Erectile dysfunction--an observable marker of Diabetes mellitus? A large national epidemiological study.
- Delayed diagnosis of psychological erectile Dysfunction because of the presence of macroprolactinemia.
- The endocrinologist as the focus in a multidisciplinary approach to management of erectile Dysfunction.
- Reproducibility in monitoring nocturnal penile tumescence and rigidity.
- Testosterone insufficiency in women: fact or fiction?
- Comparison of results of nocturnal penile tumescence and rigidity in a sleep laboratory versus a portable home monitor.
- Hypogonadism in men With erectile dysfunction may be related to a host of chronic illnesses.
- Serum androgen levels in healthy premenopausal women With and Without sexual dysfunction: Part B: Reduced serum androgen levels in healthy premenopausal women With com...
- Commentary on androgen Deficiency in women and the FDA advisory board''s recent decision to request more safety data.
- Decreased free testosterone and dehydroepiandrosterone-sulfate (DHEA-S) levels in women With decreased libido.
- Clinical experience With intraurethral alprostadil (MUSE) in the treatment of men With erectile dysfunction. A retrospective study. Medicated urethral system for erect...
- Characterization of patients in a medical endocrine-based center for Male sexual dysfunction.
- Yohimbine treatment of organic erectile Dysfunction in a dose-escalation trial.
- FeMale androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment.
- Serum androgen levels in healthy premenopausal women With and Without sexual dysfunction: Part A. Serum androgen levels in women aged 20-49 years With no complaints of...
- Sexual Dysfunction and cardiac risk (the Second Princeton Consensus Conference).
- Testosterone treatment in hypogonadal men: prostate-specific antigen level and risk of prostate cancer.
- Cessation of smoking rapidly decreases erectile Dysfunction.
- Effect of raising endogenous testosterone levels in impotent men With secondary hypogonadism: double blind placebo-controlled trial With clomiphene citrate.
- Possible hypothalamic impotence. Male counterpart to hypothalamic amenorrhea?
- Mechanisms of Obesity and related pathologies: androgen deficiency and endothelial dysfunction may be the link between Obesity and erectile dysfunction.
- The relationship between testosterone levels, the metabolic syndrome (by two criteria), and insulin resistance in a population of men With organic erectile dysfunction.
- Clomiphene increases free testosterone levels in men With both secondary hypogonadism and erectile dysfunction: who does and does not benefit?
- Impact of oral contraceptives on sex hormone-binding globulin and androgen levels: a retrospective study in women With sexual dysfunction.
- The dark side of testosterone Deficiency: III. Cardiovascular disease.
- Efficacy and safety of sildenafil citrate for treatment of erectile dysfunction in a population With associated organic risk factors.
- The dark side of testosterone deficiency: I. Metabolic Syndrome and erectile dysfunction.
- The dark side of testosterone deficiency: II. Type 2 Diabetes and insulin resistance.
- American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of Male sexual dysfunction: a couple''s pro...
- Normal, bound and nonbound testosterone levels in normally ageing men: results from the Massachusetts Male Ageing Study.
- Are the Endocrine Society''s Clinical Practice Guidelines on Androgen Therapy in Women misguided? A commentary.
- The brain, the penis and steroid hormones: clinical correlates With endothelial dysfunction.
- Assessing symptoms of hypogonadism by self-administered questionnaire: qualitative findings in patients and controls.
Schools
UMDNJ New Jersey Medical School
St Vincent Hospital
Mayo Clinic Rochester
Conditions Treated
- Adrenogenital Disorders
- Diabetes Type 2
- Diabetes With Renal Manifestations
- Goiter
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- BlueConnect HMO
- Preferred Blue PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Simplifi
- Tufts PPO
- United Healthcare
Awards
- Fellow (FACE)
Education
-
Mayo School of Graduate Medical Education -
Rutgers New Jersey Medical School
Hospital
-
Lahey Hospital & Medical Center, Burlington
Drug Facts
| NPI NUMBER | 1598865230 | |
| NPPES Provider LastName | GUAY | |
| NPPES Provider FirstName | ANDRE | |
| NPPES Provider ZIPCode | 019602901 | |
| NPPES Provider State | MA | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 602.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1598865230 |
| Last Name Of The Provider | GUAY |
| First Name Of The Provider | ANDRE |
| View All |
Similar Doctors
|
|
Dr. Howard E. Rotner, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Varsha G. Vimalananda, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Angela M. Restrepo, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Melissa L. Piech, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Leo Tchong Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Julie R. Chan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Antoine F. Arkieh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Beth M. Cohen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Grace Lee, MD
This Doctor is OpenDoctor Recommended.
|